<DOC>
	<DOCNO>NCT01100255</DOCNO>
	<brief_summary>In study investigator study effect drug call ketamine symptom Obsessive-compulsive disorder ( OCD ) .</brief_summary>
	<brief_title>Pilot Study Ketamine Adults With Obsessive-Compulsive Disorder ( OCD )</brief_title>
	<detailed_description>Obsessive-compulsive disorder ( OCD ) common psychiatric illness affect 2-3 % population . People OCD experience anxiety-provoking , intrusive thought , know obsession , feel compel perform repetitive behavior , compulsion . The medication proven effective OCD serotonin reuptake inhibitor ( SRIs ) , even SRI treatment , patient continue experience significant OCD symptom , impaired functioning , diminish quality life . Recent evidence suggest different neurotransmitter , glutamate , may contribute symptom OCD . Medications target glutamate hold promise ameliorate symptom patient continue suffer OCD . In study investigator recruit patient receive drug ketamine , think modulate neurotransmitter glutamate N-methyl-D-aspartate ( NMDA ) , 2-week placebo control study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Age 1855 Physically healthy currently pregnant Primary Diagnosis OCD Sufficient severity symptom Able provide consent Psychiatric condition make participation unsafe Currently psychotropic medication Medical condition make participation unsafe Allergy ketamine Any metal body</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>OCD</keyword>
</DOC>